Skip to main content
. 2008 Dec 23;23(6):929–936. doi: 10.3346/jkms.2008.23.6.929

Fig. 1.

Fig. 1

Comparison of anti-PRP IgG titer with SBA titers in sera after 2 doses of PRP-T vaccine (n=20 serum samples) (A), sera after 3 doses of PRP-T vaccine (n=21 serum samples) (B) and sera after 2 doses of PRP-OMP vaccine (n=21 serum samples) (C). The vertical and horizontal dotted lines represent the detection limit of anti-PRP IgG antibody assay (0.15 µg/mL) and serum bactericidal assay (2), respectively.